Glenmark Pharmaceuticals Inc., USA (Glenmark), a research-led, global pharmaceutical company, announces the launch of vancomycin hydrochloride for injection USP, 750 mg/vial, 1.25 g/vial and 1.5 ...

announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP in single-dose vials of 750 mg/vial, 1.25 g/vial and 1.5 g/vial. The company noted that its Vancomycin Hydrochloride for ...

1Glenmark's Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) is only approved for the indication(s) listed in Glenmark's approved label.

Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion ... Discontinue at the 1 st signs of severe dermatologic reactions (eg, TEN, SJS, DRESS, AGEP, LABD).